Platelet and megakaryocyte CD40L expression in β-Thalassemic patients

Thromb Res. 2020 May:189:108-111. doi: 10.1016/j.thromres.2020.02.026. Epub 2020 Mar 2.

¹ Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, Istituto Superiore di Sanità, Rome, Italy.
² Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
³ UO Talassemici Sant'Eugenio Hospital, Rome, Italy.
⁴ Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
⁵ Department of Experimental Medicine, University Sapienza, Rome, Italy.
⁶ Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, Istituto Superiore di Sanità, Rome, Italy. Electronic address: marco.gabbianelli@iss.it.

No abstract available

Keywords: Aspirin; CD40 ligand; Megakaryocytes; Platelets; β-Thalassemia.

Publication types